Supplementary E-References

Supplementary e-References

e-1. Li Y, Xie P, Lv F, et al. Brain magnetic resonance imaging abnormalities in neuromyelitis optica. Acta Neurol Scand 2008;118:218-225.

e-2. Kim JE, Kim SM, Ahn SW, et al. Brain abnormalities in neuromyelitis optica. J Neurol Sci 2011;302:43-48.

e-3. Pires CE, Silva CM, Lopes FC, et al. Brain MRI abnormalities in Brazilian patients with neuromyelitis optica. J Clin Neurosci 2012;19:969-974.

e-4. Nagaishi A, Takagi M, Umemura A, et al. Clinical features of neuromyelitis optica in a large Japanese cohort: comparison between phenotypes. J Neurol Neurosurg Psychiatry 2011;82:1360-1364.

e-5. Downer JJ, Leite MI, Carter R, Palace J, Kuker W, Quaghebeur G. Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete? Neuroradiology 2012;54:279-285.

e-6. Nakajima H, Fujiki Y, Ito T, Kitaoka H, Takahashi T. Anti-aquaporin-4 antibody-positive neuromyelitis optica presenting with syndrome of inappropriate antidiuretic hormone secretion as an initial manifestation. Case Rep Neurol 2011;3:263-267.

e-7. Baba T, Nakashima I, Kanbayashi T, et al. Narcolepsy as an initial manifestation of neuromyelitis optica with anti-aquaporin-4 antibody. J Neurol 2009;256:287-288.

e-8. Suzuki K, Nakamura T, Hashimoto K, et al. Hypothermia, hypotension, hypersomnia, and obesity associated with hypothalamic lesions in a patient positive for the anti-aquaporin 4 antibody: a case report and literature review. Arch Neurol 2012;69:1355-1359.

e-9. Poppe AY, Lapierre Y, Melancon D, et al. Neuromyelitis optica with hypothalamic involvement. Mult Scler 2005;11:617-621.

e-10. Lu Z, Qiu W, Zou Y, et al. Characteristic linear lesions and longitudinally extensive spinal cord lesions in Chinese patients with neuromyelitis optica. J Neurol Sci 2010;293:92-96.

e-11. Hage R, Jr., Merle H, Jeannin S, Cabre P. Ocular oscillations in the neuromyelitis optica spectrum. J Neuroophthalmol 2011;31:255-259.

e-12. Shinoda K, Matsushita T, Furuta K, et al. Wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) syndrome in a patient with neuromyelitis optica spectrum disorder and anti-aquaporin-4 antibody. Mult Scler 2011;17:885-887.

e-13. Simon JH, Holtas SL, Schiffer RB, et al. Corpus callosum and subcallosal-periventricular lesions in multiple sclerosis: detection with MR. Radiology 1986;160:363-367.

e-14. Gean-Marton AD, Vezina LG, Marton KI, et al. Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis. Radiology 1991;180:215-221.

e-15. Makino T, Ito S, Mori M, Yonezu T, Ogawa Y, Kuwabara S. Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica. Mult Scler 2013;19:308-315.

e-16. Kim W, Kim SH, Huh SY, Kim HJ. Brain abnormalities in neuromyelitis optica spectrum disorder. Mult Scler Int 2012;2012:735486.

e-17. Graber JJ, Kister I, Geyer H, Khaund M, Herbert J. Neuromyelitis optica and concentric rings of Balo in the brainstem. Arch Neurol 2009;66:274-275.

e-18. Kreft KL, Mellema SJ, Hintzen RQ. Spinal cord involvement in Balo's concentric sclerosis. J Neurol Sci 2009;279:114-117.

e-19. Nakamura M, Endo M, Murakami K, Konno H, Fujihara K, Itoyama Y. An autopsied case of neuromyelitis optica with a large cavitary cerebral lesion. Mult Scler 2005;11:735-738.

e-20. Kim SH, Huh SY, Hyun JW, et al. A longitudinal brain magnetic resonance imaging study of neuromyelitis optica spectrum disorder. PLOS ONE 2014;9:e108320

e-21. Banker P, Sonni S, Kister I, Loh JP, Lui YW. Pencil-thin ependymal enhancement in neuromyelitis optica spectrum disorders. Mult Scler 2012;18:1050-1053.

e-22. Rocca MA, Hickman SJ, Bo L, et al. Imaging the optic nerve in multiple sclerosis. Mult Scler 2005;11:537-541.

e-23. Kim SH, Kim SM, Vincent A, et al. Clinical characteristics, prognosis, and seropositivity to the anti-aquaporin-4 antibody in Korean patients with longitudinally extensive transverse myelitis. J Neurol 2010;257:920-925.

e-24. Oshio K, Binder DK, Yang B, Schecter S, Verkman AS, Manley GT. Expression of aquaporin water channels in mouse spinal cord. Neuroscience 2004;127:685-693.

e-25. Verhey LH, Branson HM, Makhija M, Shroff M, Banwell B. Magnetic resonance imaging features of the spinal cord in pediatric multiple sclerosis: a preliminary study. Neuroradiology 2010;52:1153-1162.

e-26. Chen L, Li J, Guo Z, Liao S, Jiang L. Prognostic indicators of acute transverse myelitis in 39 children. Pediatr Neurol 2013;49:397-400.

e-27. Thomas T, Branson HM. Childhood transverse myelitis and its mimics. Neuroimaging Clin N Am 2013;23:267-278.

e-28. Kanamori Y, Nakashima I, Takai Y, et al. Pain in neuromyelitis optica and its effect on quality of life: a cross-sectional study. Neurology 2011;77:652-658.

e-29. Takano R, Misu T, Takahashi T, Sato S, Fujihara K, Itoyama Y. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study. Neurology 2010;75:208-216.

e-30. Cheng C, Jiang Y, Chen X, et al. Clinical, radiographic characteristics and immunomodulating changes in neuromyelitis optica with extensive brain lesions. BMC Neurol 2013;13:72.

e-31. Kister I, Ge Y, Herbert J, Sinnecker T, Wuerfel J, Paul F. Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurology 2013;81:1966.

e-32. Titulaer MJ,Höftberger R,Iizuka T,et al. Overlapping demyelinating syndromes and anti–N-methyl-D-aspartatereceptor encephalomyelitis. Ann Neurol. 2014;75:411-428

e-33. Watanabe M, Kondo T, Murakata K, et al. Antibodies to neural and non-neural autoantigens in Japanese patients with CNS demyelinating disorders. J Neuroimmunol 2014;274:155-160